cccDNA Inhibitors (Novira Therapeutics)

N/A

Report date: 2025/03/19 08:59:44
NME

Base Information

Drug NamecccDNA Inhibitors (Novira Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovira Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesNovira Therapeutics Inc
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A